Early Drug Development: Strategies and Routes to First-in-Human Trials | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
A01=Cram101 Textbook Reviews
Age Group_Uncategorized
Age Group_Uncategorized
Author_Cram101 Textbook Reviews
automatic-update
B01=Mitchell N. Cayen
Category1=Non-Fiction
Category=MMG
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Early Drug Development: Strategies and Routes to First-in-Human Trials

English

By (author): Cram101 Textbook Reviews

The focus of early drug development has been the submission of an Investigational New Drug application to regulatory agencies. Early Drug Development: Strategies and Routes to First-in-Human Trials guides drug development organizations in preparing and submitting an Investigational New Drug (IND) application. By explaining the nuts and bolts of preclinical development activities and their interplay in effectively identifying successful clinical candidates, the book helps pharmaceutical scientists determine what types of discovery and preclinical research studies are needed in order to support a submission to regulatory agencies. See more
Current price €152.51
Original price €163.99
Save 7%
A01=Cram101 Textbook ReviewsAge Group_UncategorizedAuthor_Cram101 Textbook Reviewsautomatic-updateB01=Mitchell N. CayenCategory1=Non-FictionCategory=MMGCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 1118g
  • Dimensions: 160 x 240mm
  • Publication Date: 23 Jul 2010
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781428845572

About Cram101 Textbook Reviews

MITCHELL N. CAYEN PhD is Principal of Cayen Pharmaceutical Consulting LLC a firm that advises pharmaceutical companies in nonclinical and clinical drug develop-ment with specific focus on candidate drug selection discovery drug metabolism and pharmacokinetics drug development strategies and regulatory submissions. Previously he was senior director of drug metabolism and pharmacokinetics at Schering-Plough Research Institute.

Customer Reviews

No reviews yet
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept